BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1280431)

  • 1. Protein tyrosine phosphorylation as an indicator of 2,3,7,8-tetrachloro-p-dioxin exposure in vivo and in vitro.
    Ma X; Mufti NA; Babish JG
    Biochem Biophys Res Commun; 1992 Nov; 189(1):59-65. PubMed ID: 1280431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
    Shen ES; Guengerich FP; Olson JR
    Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases.
    Ma X; Babish JG
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1070-7. PubMed ID: 7506535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain.
    Unkila M; Pohjanvirta R; Honkakoski P; Törrönen R; Tuomisto J
    Biochem Pharmacol; 1993 Aug; 46(4):651-9. PubMed ID: 8363638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation.
    DeVito MJ; Ma X; Babish JG; Menache M; Birnbaum LS
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):82-90. PubMed ID: 8291065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    DeVito MJ; Beebe LE; Menache M; Birnbaum LS
    J Toxicol Environ Health; 1996 Mar; 47(4):379-94. PubMed ID: 8600290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ethoxyresorufin-O-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Stohs SJ; Abbott BD; Lin FH; Birnbaum LS
    Toxicology; 1990 Dec; 65(1-2):123-36. PubMed ID: 2274963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uroporphyrin accumulation associated with cytochrome P4501A induction in fish hepatoma cells exposed to aryl hydrocarbon receptor agonists, including 2,3,7,8-tetrachlorodibenzo-p-dioxin and planar chlorobiphenyls.
    Hahn ME; Chandran K
    Arch Biochem Biophys; 1996 May; 329(2):163-74. PubMed ID: 8638948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.
    Abraham K; Krowke R; Neubert D
    Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic microsomal ethoxyresorufin O-deethylase-inducing potency in ovo and cytosolic Ah receptor binding affinity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: comparison of four avian species.
    Sanderson JT; Bellward GD
    Toxicol Appl Pharmacol; 1995 May; 132(1):131-45. PubMed ID: 7747276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
    Döhr O; Vogel C; Abel J
    Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) distribution and cytochrome P4501A induction in young adult and senescent male mice.
    Pegram RA; Diliberto JJ; Moore TC; Gao P; Birnbaum LS
    Toxicol Lett; 1995 Mar; 76(2):119-26. PubMed ID: 7725343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
    Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
    Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
    Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the epidermal growth factor receptor in hepatic plasma membranes of rainbow trout (Oncorhynchus mykiss).
    Newsted JL; Giesy JP
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):41-51. PubMed ID: 8470122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative sensitivities of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced Cyp1a-1 and Cyp1a-2 gene expression and immunotoxicity in female B6C3F1 mice.
    Narasimhan TR; Craig A; Arellano L; Harper N; Howie L; Menache M; Birnbaum L; Safe S
    Fundam Appl Toxicol; 1994 Nov; 23(4):598-607. PubMed ID: 7867912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor.
    Schrenk D; Schäfer S; Bock KW
    Carcinogenesis; 1994 Jan; 15(1):27-31. PubMed ID: 8293544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
    Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
    Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
    van Duursen MB; Sanderson JT; van den Berg M
    Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.